Volume 121, Issue 5, Pages (November 2001)

Slides:

Advertisements

Similar presentations

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Advertisements

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.

It's time to bring the best and brightest back to gastroenterology!

AGA technical review on irritable bowel syndrome

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Metronidazole susceptibility in Helicobacter pylori

Prevalence of Barrett's esophagus in asymptomatic individuals

Volume 125, Issue 3, Pages (September 2003)

Volume 114, Issue 3, Pages (March 1998)

L. Boyanova Clinical Microbiology and Infection

Volume 119, Issue 3, Pages (September 2000)

First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori Stephan Timm, Marco Sailer, Karl–hermann.

Diagnosis of irritable bowel syndrome

Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Alexander C. Ford, Khurram J. Khan, William.

Volume 119, Issue 2, Pages (August 2000)

Leptin, obesity, and liver disease

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Volume 137, Issue 5, Pages e2 (November 2009)

American Gastroenterological Association Technical Review on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts James M. Scheiman,

Polyxeni Koutkia, Zhiren Lu, Tai C. Chen, Michael F. Holick

Volume 122, Issue 7, Pages (June 2002)

Volume 129, Issue 5, Pages (November 2005)

Volume 124, Issue 4, Pages (April 2003)

PPI-based triple therapy in the eradication of H. pylori infection

Volume 114, Issue 3, Pages (March 1998)

Metronidazole susceptibility in Helicobacter pylori

American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease Peter J. Kahrilas, Nicholas.

Volume 129, Issue 6, Pages (December 2005)

Hepatitis B infection in heart transplant recipients

Volume 128, Issue 7, Pages (June 2005)

Appendectomy is followed by increased risk of Crohn's disease

Volume 123, Issue 2, Pages (August 2002)

Volume 120, Issue 3, Pages (February 2001)

Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§

Prevalence of Barrett's esophagus in asymptomatic individuals

Volume 120, Issue 4, Pages (March 2001)

A. Cosme, M. Montes, M. Martos, I. Gil, U. Mendarte, Y. Salicio, L

Ronnie Fass, Stephen J. Sontag, Barry Traxler, Mark Sostek

Volume 122, Issue 7, Pages (June 2002)

Volume 116, Issue 2, Pages (February 1999)

Volume 124, Issue 4, Pages (April 2003)

Volume 119, Issue 1, Pages (July 2000)

Volume 118, Issue 4, Pages (April 2000)

Volume 121, Issue 4, Pages (October 2001)

Peter Bytzer Clinical Gastroenterology and Hepatology

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Brennan M.R. Spiegel, Nimish B. Vakil, Joshua J. Ofman

Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease A. Pali S. Hungin, Catherine Hill, Michael.

Volume 149, Issue 6, Pages (November 2015)

Volume 121, Issue 5, Pages (November 2001)

Image of the month Gastroenterology

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease–Like Symptoms But Normal Endoscopy and 24-Hour pH Testing Michael.

Volume 119, Issue 4, Pages (October 2000)

Volume 127, Issue 5, Pages (November 2004)

AGA technical review on osteoporosis in gastrointestinal diseases

Volume 122, Issue 4, Pages (April 2002)

Volume 128, Issue 7, Pages (June 2005)

Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi Gastroenterology

Mesalamine and relapse prevention in Crohn's disease

This Month in AJKD American Journal of Kidney Diseases

Nicholas J. Talley, Nimish B. Vakil, Paul Moayyedi Gastroenterology

Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass

Volume 121, Issue 4, Pages (October 2001)

Predictors of response to infliximab in patients with Crohn's disease

Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization.

This Month in AJKD American Journal of Kidney Diseases

Presentation transcript:

Volume 121, Issue 5, Pages 1120-1126 (November 2001) Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease Paul Moayyedi, Chandu Bardhan, Lynne Young, Michael F. Dixon, Lorna Brown, Anthony T.R. Axon Gastroenterology Volume 121, Issue 5, Pages 1120-1126 (November 2001) DOI: 10.1053/gast.2001.29332 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Summary of the trial design. Gastroenterology 2001 121, 1120-1126DOI: (10.1053/gast.2001.29332) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Flow diagram of the progress of participants. Gastroenterology 2001 121, 1120-1126DOI: (10.1053/gast.2001.29332) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 Gastroesophageal remission curves from 0 to 12 months for the antibiotic, placebo, and H. pylori–negative groups. Gastroenterology 2001 121, 1120-1126DOI: (10.1053/gast.2001.29332) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 4 Remission curves from 12 to 18 months for the antibiotic, placebo, and H. pylori–negative groups in patients with no previous relapse. Gastroenterology 2001 121, 1120-1126DOI: (10.1053/gast.2001.29332) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 5 Remission curves from 12 to 18 months for the antibiotic, placebo, and H. pylori–negative groups in patients with previous relapse. Gastroenterology 2001 121, 1120-1126DOI: (10.1053/gast.2001.29332) Copyright © 2001 American Gastroenterological Association Terms and Conditions